SMTL ID : 9dmg.1

Human muscle nAChR apo state

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-2-1-1-1-mer

Ligands

1 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN.1: 11 residues within 4Å: Chain A: N.161, S.163, E.200, W.204, K.205, H.206, S.207, T.222, H.224, V.226 Ligands: MAN.8 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:W.204 Hydrogen bonds: A:W.204

3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN.2: 9 residues within 4Å: Chain B: N.161, S.163, W.204, K.205, H.206, S.207, T.222, H.224, V.226 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:H.206 NAG-NAG-BMA-MAN-MAN.3: 15 residues within 4Å: Chain C: W.162, N.164, T.166, R.216, I.218, I.236, Y.238, I.240, P.496, D.498, P.499, F.500, P.501, S.502, R.503 4 PLIP interactions: 4 interactions with chain C Hydrophobic interactions: C:I.218, C:F.500 Hydrogen bonds: C:Y.238, C:P.501 NAG-NAG-BMA-MAN-MAN.4: 13 residues within 4Å: Chain D: W.162, N.164, R.219, N.221, D.223, P.224, R.225, Y.239, I.241, P.498, P.501, F.502, P.503 2 PLIP interactions: 2 interactions with chain D Hydrogen bonds: D:Y.239, D:P.503

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.5: 6 residues within 4Å: Chain E: R.43, Y.83, N.86, S.88, G.133, G.134 No protein-ligand interaction detected (PLIP)

1 x NAG- NAG- BMA- BMA- MAN- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-BMA-MAN-MAN.6: 12 residues within 4Å: Chain E: W.159, N.161, S.163, V.213, R.215, H.217, H.218, I.231, S.233, I.235, P.483, L.485 No protein-ligand interaction detected (PLIP)

4 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)

POV.7: 17 residues within 4Å: Chain A: T.153, V.291, K.296, L.299, F.300, V.303, F.304, A.307, I.311, V.433, F.434, V.437 Chain E: L.241, V.244, I.245, V.249, L.253 9 PLIP interactions: 8 interactions with chain A, 1 interactions with chain E Hydrophobic interactions: A:V.291, A:K.296, A:L.299, A:F.300, A:V.303, A:I.311, A:F.434, A:V.437, E:L.253 POV.12: 18 residues within 4Å: Chain C: L.261, F.265, Y.268, R.469, L.472, W.473 Chain D: M.322, V.325, I.326, I.329, I.333, R.336, H.341, V.347, F.351, W.462, V.465, V.469 12 PLIP interactions: 9 interactions with chain D, 3 interactions with chain C Hydrophobic interactions: D:V.325, D:I.326, D:I.333, D:V.347, D:V.347, D:F.351, D:F.351, D:W.462, C:F.265, C:Y.268 Salt bridges: D:R.336, C:R.469 POV.15: 18 residues within 4Å: Chain C: L.246, L.249, V.250, I.253, A.254, I.257, F.487 Chain D: T.156, A.305, I.306, K.311, L.314, F.315, V.318, L.319, M.322, I.488 Ligands: CLR.11 9 PLIP interactions: 7 interactions with chain D, 2 interactions with chain C Hydrophobic interactions: D:L.314, D:L.314, D:F.315, D:F.315, D:V.318, D:L.319, C:A.254, C:I.257 Hydrogen bonds: D:I.306 POV.18: 25 residues within 4Å: Chain A: I.306, I.310, V.313, I.314, N.317, R.321, H.326 Chain E: V.252, L.253, G.256, L.257, L.259, L.260, Y.262, F.263, L.264, P.265, K.272, N.452, D.455, N.456, F.459, W.460, L.463, F.466 17 PLIP interactions: 6 interactions with chain A, 11 interactions with chain E Hydrophobic interactions: A:I.310, A:I.314, E:L.253, E:L.259, E:L.260, E:F.263, E:F.263, E:F.263, E:F.263, E:F.459, E:L.463, E:F.466 Hydrogen bonds: A:N.317, A:N.317 Salt bridges: A:R.321, A:H.326, E:D.455

1 x MAN: alpha-D-mannopyranose(Non-functional Binders)

MAN.8: 3 residues within 4Å: Chain A: K.205, S.207 Ligands: NAG-NAG-BMA-MAN-MAN-MAN.1 No protein-ligand interaction detected (PLIP)

7 x CLR: CHOLESTEROL(Non-covalent)

CLR.9: 11 residues within 4Å: Chain B: L.299, V.303, I.306, A.307, I.310 Chain D: L.247, I.250, I.251, V.255, L.259 Ligands: CLR.14 4 PLIP interactions: 1 interactions with chain B, 3 interactions with chain D Hydrophobic interactions: B:V.303, D:I.250, D:I.251, D:V.255 CLR.10: 10 residues within 4Å: Chain A: L.232, V.236, I.240 Chain C: L.303, S.304, V.305, K.310, M.313, F.314, V.317 5 PLIP interactions: 4 interactions with chain C, 1 interactions with chain A Hydrophobic interactions: C:K.310, C:M.313, C:F.314, C:V.317, A:L.232 CLR.11: 12 residues within 4Å: Chain C: I.257, T.260, L.261, I.264, T.479, S.480, T.483, L.484, F.487, L.488, T.491 Ligands: POV.15 6 PLIP interactions: 6 interactions with chain C Hydrophobic interactions: C:T.260, C:L.261, C:T.483, C:L.484, C:L.484, C:T.491 CLR.13: 10 residues within 4Å: Chain D: V.258, F.262, V.482, T.485, A.486, F.489, L.490, V.493, Y.494 Ligands: CLR.14 5 PLIP interactions: 5 interactions with chain D Hydrophobic interactions: D:F.262, D:T.485, D:L.490, D:V.493, D:V.493 CLR.14: 11 residues within 4Å: Chain D: F.160, P.246, I.250, L.254, V.255, V.258, L.259, F.489, V.493 Ligands: CLR.9, CLR.13 8 PLIP interactions: 8 interactions with chain D Hydrophobic interactions: D:F.160, D:F.160, D:I.250, D:I.250, D:L.254, D:V.258, D:F.489, D:V.493 CLR.16: 10 residues within 4Å: Chain E: T.153, Y.154, S.300, V.301, R.306, F.310, G.469, L.472, I.473 Ligands: CLR.17 2 PLIP interactions: 2 interactions with chain E Hydrophobic interactions: E:T.153, E:I.473 CLR.17: 11 residues within 4Å: Chain B: L.232, V.236, I.240 Chain E: L.299, S.300, V.301, R.306, I.309, F.310, V.313 Ligands: CLR.16 4 PLIP interactions: 1 interactions with chain B, 3 interactions with chain E Hydrophobic interactions: B:L.232, E:V.301, E:I.309, E:V.313

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Li, H. et al., Structure of human muscle AChR apo state. To Be Published

Release Date

2025-04-09

Peptides

Acetylcholine receptor subunit alpha: AB
Acetylcholine receptor subunit beta: C
Acetylcholine receptor subunit delta: D
Acetylcholine receptor subunit epsilon: E

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
C

C
E

D
D

E
B

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Acetylcholine receptor subunit alpha

Acetylcholine receptor subunit beta

Acetylcholine receptor subunit delta

Acetylcholine receptor subunit epsilon

Related Entries With Identical Sequence